Bragar Eagel & Squire Reminds Investors of Class Action Lawsuits Against PomDoctor and Inovio

Law firm encourages investors to contact them regarding pending cases against the two companies.

Published on Mar. 9, 2026

Got story updates? Submit your updates here. ›

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, has reminded investors that class action lawsuits have been filed on behalf of stockholders of PomDoctor, Ltd. (NASDAQ:POM) and Inovio Pharmaceuticals, Inc. (NASDAQ:INO). The lawsuits allege the companies made materially false and/or misleading statements during the respective class periods. Investors have until April 7, 2026 to petition the court to serve as lead plaintiff in the cases.

Why it matters

These class action lawsuits highlight ongoing concerns about potential fraud and misconduct in the stock market, particularly related to companies accused of making false or misleading statements to investors. The cases could result in significant financial penalties and damages for the companies if the allegations are proven.

The details

The PomDoctor lawsuit alleges the company was the subject of a fraudulent stock promotion scheme involving social media-based misinformation and impersonated financial professionals. It also claims insiders and/or affiliates used offshore or nominee accounts to facilitate the coordinated dumping of shares during a price inflation campaign. The Inovio lawsuit alleges the company made false and/or misleading statements about manufacturing issues with its CELLECTRA device, the timing of its Biologics License Application (BLA) submission, and the eligibility of its treatment INO-3107 for FDA accelerated approval or priority review.

  • The PomDoctor class period is from October 9, 2025 to December 11, 2025.
  • The Inovio class period is from October 10, 2023 to December 26, 2025.
  • The lead plaintiff deadline for both cases is April 7, 2026.

The players

Bragar Eagel & Squire, P.C.

A nationally recognized shareholder rights law firm with offices in New York, South Carolina, and California. The firm represents individual and institutional investors in securities, derivative, and commercial litigation as well as individuals in consumer protection and data privacy litigation.

PomDoctor, Ltd.

A company trading on the NASDAQ exchange that is accused of being involved in a fraudulent stock promotion scheme.

Inovio Pharmaceuticals, Inc.

A pharmaceutical company trading on the NASDAQ exchange that is accused of making false and/or misleading statements about its CELLECTRA device manufacturing and the regulatory prospects of its treatment INO-3107.

Got photos? Submit your photos here. ›

What’s next

Investors have until April 7, 2026 to petition the court to serve as lead plaintiff in the class action lawsuits against PomDoctor and Inovio.

The takeaway

These class action lawsuits underscore the importance for investors to thoroughly research companies and be wary of potential fraud or misleading information, especially related to small or speculative stocks. The outcomes of these cases could have broader implications for stock market integrity and investor protections.